Skip to main content
. 2020 Nov 4;10(66):40244–40263. doi: 10.1039/d0ra08304f

Optimization of P1 residue of new candidates for the SARS-CoV-2 Mpro α-ketoamide inhibitorsa.

Compound Formula: P3–P2–P1–P1′ ΔΔEint,MMa [kcal mol−1] M w b [g mol−1]
C1 graphic file with name d0ra08304f-u17.jpg 6.6 506.6
11n graphic file with name d0ra08304f-u18.jpg 7.6 532.6
C2 graphic file with name d0ra08304f-u19.jpg 3.5 530.6
C3 graphic file with name d0ra08304f-u20.jpg 5.2 530.6
C4 graphic file with name d0ra08304f-u21.jpg 1.3 547.6
a

a,bSee the footnote of Table 1.